[2] [2] JUE T R, MCDONALD K L. The challenges associated with molecular targeted therapies for glioblastoma ［J］. Journal of Neuro-oncology, 2016, 127(3): 427-434.

[3] [3] HE J, ZHENG N S, LI H, et al. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas ［J］. Oncology Reports, 2011, 26(5): 1305-1313.

[4] [4] KNIZHNIK A V, WYNAND P R, TEODORA N, et al. Survival and death strategies in glioma cells: autophagy, senescence and apoptosis triggered by a single type of temozolomide-induced DNA damage ［J］. PLoS One, 2013, 8(1): e55665.

[5] [5] AUFFINGER B, SPENCER D, PYTEL P, et al. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence ［J］. Expert Review of Neurotherapeutics, 2016, 15(7): 741-752.

[6] [6] HU J, YUAN X, XU Q, et al. Cancer stem cells in glioblastoma ［J］. Genes Development, 2012, 29(12): 1203-1217.

[7] [7] ZEISBERG M, NEILSON E G. Biomarkers for epithelial-mesenchymal transitions ［J］. Journal of Clinical Investigation, 2009, 119(6): 1429-1437.

[8] [8] LIANG S Q, MARTI T M, DORN P, et al. Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer ［J］. Cell Death & Disease, 2015, 6(7): e1824.

[9] [9] YANG A D, FAN F, CAMP E R, et al. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines ［J］. Clinical Cancer Research, 2006, 12(14): 4147-4153.

[10] [10] WANG Z W, LI Y W, KONG D J, et al. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway ［J］. Cancer Researh, 2009, 69(6): 2400-2407.

[11] [11] WOLF F W, MARKS R M, SARMA V, et al. Characterization of a novel tumor necrosis factor-alpha-induced endothelial primary response gene ［J］. Journal of Biological Chemistry, 1992, 267(2): 1317-1326.

[12] [12] ZHOU J L, HU X X, XIONG X W, et al. Cloning of two rat PDIP1 related genes and their interactions with proliferating cell nuclear antigen ［J］. Journal of Experimental Zoology Part A Comparative Experimental Biology, 2005, 303(3): 227-240.

[13] [13] SAILLAND J, TRIBOLLET V, FORCET C, et al. Estrogen-related receptor α decreases RHOA stability to induce orientated cell migration ［J］. Proceedings of the National Academy of Sciences of the United States of America, 2014, 111(42): 15108-15113.

[14] [14] CUI R, KIM T, FASSAN M, et al. MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7 ［J］. Oncotarget, 2015, 6(26): 21802-21815.

[15] [15] CUI R, MENG W, SUN H L, et al. MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer ［J］. Proceedings of the National Academy of Ences of the United States of America, 2015, 112(31): E4288-4298.

[16] [16] KIM D M, CHUNG K S, CHOI S J, et al. RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells ［J］. International Journal of Cancer, 2010, 125(11): 2520-2527.

[17] [17] LIN M C, LEE N P, ZHENG N, et al. Tumor necrosis factor-a-induced protein 1 and immunity to hepatitis B virus［J］. World Journal of Gastroenterology, 2005, 11(48): 7564-7568.

[18] [18] QIU F, ZHOU Y B, DENG Y K, et al. Knockdown of TNFAIP1 prevents di-(2-ethylhexyl) phthalate-induced neurotoxicity by activating CREB pathway［J］. Chemosphere, 2020, 241: 125114.

[19] [19] XIAO Y, HUANG S L, QIU F, et al. Tumor necrosis factor a-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-kB activation in hepatocellular carcinoma ［J］. EBioMedicine, 2020, 51: 10263.

[21] [21] HUANG W H, ZHONG Z, LUO C, et al. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma ［J］. Theranostics, 2019, 9(19): 5497-5516.

[22] [22] BLEAU A M, HUSE J T, HOLLAND E C. The ABCG2 resistance network of glioblastoma ［J］. Cell Cycle, 2009, 8(18): 2937-2945.

[23] [23] WU M, XU L, TENG C, et al. Involvement of oxidative stress in di-2-ethylhexyl phthalate (DEHP)-induced apoptosis of mouse NE-4C neural stem cells ［J］. Neurotoxicology, 2018, 70(1): 41-71.

[24] [24] WON E K, KIM Y , HA M , et al. Association of current phthalate exposure with neurobehavioral development in a national sample ［J］. International Journal of Hygiene & Environmental Health, 2016, 219(5): 364-371.

[25] [25] YANG L, LIU N, HU X, et al. CK2 phosphorylates TNFAIP1 to affect its subcellular localization and interaction with PCNA ［J］. Molecular Biology Reports, 2010, 37(6): 2967-2973.

[26] [26] TAN Z W, XIE S, HU S Y, et al. Caudatin targets TNFAIP1/NF-κB and cytochrome c/caspase signaling to suppress tumor progression in human uterine cancer ［J］. International Journal of Oncology, 2016, 49(1): 1638-1650.

[27] [27] ZHANG X, LI X, TAN Z, et al. MicroRNA-373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis ［J］. Oncology Letters, 2013, 6(1): 1427-1434.

[29] [29] LI W, ZHANG X, WANG J, et al. TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells ［J］. Oncotarget, 2017, 8(56): 96035-96047.

[30] [30] SUN X, ZHANG T, DENG Q, et al. Benzidine induces epithelial-mesenchymal transition of human bladder cancer cells through activation of ERK5 pathway ［J］. Molecules & Cells, 2018, 41(3): 188-197.

[31] [31] TANG L, SUN W. MDM2 increases drug resistance in cancer cells by inducing EMT independent of p53 ［J］. Current Medicinal Chemistry, 2016, 23(40): 4529-4539.

[32] [32] WANG M, REN D, GUO W, et al. N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells ［J］. International Journal of Oncology, 2016, 48(2): 595-606.

[33] [33] LAMOUILLE S, XU J, DERYNCK R. Molecular mechanisms of epithelial-mesenchymal transition ［J］. Nature Reviews Molecular Cell Biology, 2014, 15(3): 178-196.

[34] [34] YANG M H, CHEN C L, CHAU G Y, et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma ［J］. Hepatology, 2009, 50(5): 1464-1474.

[35] [35] HéCTOR P, DAVID O, CANO A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? ［J］. Nature Reviews Cancer, 2007, 7(6): 415-428.

[36] [36] WIJNHOVEN B P, DINJENS W N, PIGNATELLI M. E-cadherin-catenin cell-cell adhesion complex and human cancer ［J］. British Journal of Plastic Surgery, 2000, 87(8): 992-1005.